MedPath

Hospital Regional Tlalnepantla

🇲🇽Mexico
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

3 Phases

Phase 2:1
Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 4
1 (33.3%)

Hyaluronic Acid in Overuse Knee Pain

Phase 2
Completed
Conditions
Overuse Injury
Overuse Injury
Body Mass Index in Athletes
Interventions
Drug: KNEE JOINT INFILTRATION WITH HYALURONIC ACID WITH SORBITOL SYNOLIS VA
First Posted Date
2022-07-08
Last Posted Date
2025-07-22
Lead Sponsor
Hospital Regional Tlalnepantla
Target Recruit Count
64
Registration Number
NCT05450458
Locations
🇲🇽

Issemym Tlalnepantla, Tlanepantla, Mexico

Femur Transtrochanteric Fractures Treated With Dynamic Hip Screw and Calcium Sulfate Scaffold.

Not Applicable
Completed
Conditions
Proximal Femur Fracture
First Posted Date
2021-10-25
Last Posted Date
2021-10-25
Lead Sponsor
Hospital Regional Tlalnepantla
Target Recruit Count
36
Registration Number
NCT05091359

Prophylaxis of Periprosthetic Joint Infections With Calcium Sulfate Beads in Patients With Non-modifiable Risk Factors.

Phase 4
Completed
Conditions
Infection
First Posted Date
2019-06-06
Last Posted Date
2020-08-20
Lead Sponsor
Hospital Regional Tlalnepantla
Target Recruit Count
87
Registration Number
NCT03976466
Locations
🇲🇽

HOSPITAL REGIONAL TLALNEPANTLA ISSEMyM, Tlalnepantla, Mexico

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.